Valuation : Phaarmasia Limited

Market Cap 513M 5.43M 4.69M 4.42M 4.02M 7.52M 7.58M 52.29M 20.29M 262M 20.41M 19.96M 862M P/E 2024
-38.3x
P/E 2025 -12.6x
Enterprise Value 511M 5.41M 4.67M 4.4M 4.01M 7.49M 7.55M 52.09M 20.22M 261M 20.33M 19.89M 859M EV / Sales 2024
0.64x
EV / Sales 2025 0.81x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day-5.00%
1 week+18.82%
Current month-9.72%
1 month+1.86%
3 months+13.58%
6 months+4.28%
Current year-19.90%
1 week 77.35
Extreme 77.35
104.95
1 month 67
Extreme 67
104.95
Current year 67
Extreme 67
131.75
1 year 30.01
Extreme 30.01
131.75
3 years 23.51
Extreme 23.51
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 2016-02-11
Compliance Officer - 2020-01-02
Director TitleAgeSince
Chairman 71 2010-10-13
Director/Board Member 55 2012-12-08
Director/Board Member 63 2012-12-18
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%+18.82%+177.85%+263.38% 6.84M
+0.29%-2.19%+58.24%+108.41% 1,034B
+1.33%+1.79%+54.35%+71.05% 654B
+0.16%-1.03%+22.78%+78.09% 459B
+0.49%-5.19%+33.28%+35.53% 343B
+0.27%+3.26%+29.76%+47.50% 307B
+0.12%-2.11%+0.60%+12.03% 251B
+0.47%-0.15%+53.23%+73.09% 237B
+2.64%-1.08%-15.85%-53.97% 202B
-0.15%+1.05%+32.77%+99.11% 186B
Average +0.07%-0.08%+44.70%+73.42% 367.16B
Weighted average by Cap. +0.58%-3.31%+38.78%+67.82%

Financials

2024 2025
Net sales 306M 3.24M 2.79M 2.63M 2.4M 4.48M 4.52M 31.16M 12.09M 156M 12.16M 11.9M 514M 244M 2.58M 2.23M 2.1M 1.91M 3.57M 3.6M 24.82M 9.63M 125M 9.69M 9.48M 409M
Net income -5.18M -54.86K -47.32K -44.58K -40.62K -75.92K -76.49K -528K -205K -2.65M -206K -201K -8.7M -15.89M -168K -145K -137K -125K -233K -235K -1.62M -628K -8.13M -632K -618K -26.69M
Net Debt -3.43M -36.33K -31.34K -29.53K -26.9K -50.28K -50.66K -350K -136K -1.75M -136K -133K -5.76M -1.94M -20.5K -17.69K -16.66K -15.18K -28.38K -28.59K -197K -76.57K -990K -77K -75.31K -3.25M
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
36
Date Price Change Volume
26-09-02 90.30 -5.00% 131
26-09-01 ₹95.05 -4.97% 1,318
26-08-31 ₹100.02 +4.63% 7,880
26-08-28 ₹95.59 +10.00% 1,979
26-08-27 ₹86.90 +5.46% 1,494
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock